Surfactant kinetics in preterm infants on mechanical ventilation who did and did not develop bronchopulmonary dysplasia

Critical Care Medicine

Volumn 31, Issue 5, 2003, Pages 1532-1538

  Cogo, Paola E ^a   Zimmermann, Luc J I ^b   Pesavento, Roberta ^a   Sacchetto, Elisabetta ^a   Burighel, Aldo ^c   Rosso, Federica ^a   Badon, Tamara ^a   Verlato, Giovanna ^a   Carnielli, Virgilio P ^c  

^a UNIVERSITY OF PADOVA   (Italy)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

Bronchopulmonary dysplasia; Kinetics; Phosphatidylcholines; Phospholipids; Pulmonary surfactant; Stable isotopes

Indexed keywords

CARBON 13; DIPALMITOYLPHOSPHATIDYLCHOLINE; PHOSPHOLIPID; SURFACTANT;

ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CONTROLLED STUDY; GAS CHROMATOGRAPHY; HALF LIFE TIME; HUMAN; INFANT; KINETICS; LUNG DYSPLASIA; MASS SPECTROMETRY; NEWBORN INTENSIVE CARE; PREMATURITY; PRIORITY JOURNAL;

1,2-DIPALMITOYLPHOSPHATIDYLCHOLINE; AIRWAY RESISTANCE; BIRTH WEIGHT; BRONCHOPULMONARY DYSPLASIA; CARBON ISOTOPES; CASE-CONTROL STUDIES; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GESTATIONAL AGE; HALF-LIFE; HUMANS; INFANT, NEWBORN; INSTILLATION, DRUG; PHOSPHATIDYLCHOLINES; PRESSURE; PULMONARY SURFACTANTS; REGRESSION ANALYSIS; RESPIRATION, ARTIFICIAL; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SPUTUM; TIME FACTORS;

EID: 0038581176     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000063043.25167.99     Document Type: Article

References (34)

1. Jobe AH, Bancalari E: Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 163:1723-1729
2. Jobe AH, Ikegami M: Antenatal infection/inflammation and postnatal lung maturation and injury. Respir Res 2001; 2:27-32
3. Coalson JJ, Winter VT, Siler-Khodr T, et al: Neonatal chronic lung disease in extremely immature baboons. Am J Respir Crit Care Med 1999; 160:1333-1346
4. Warner BB, Stuart LA, Papes RA, et al: Functional and pathological effects of prolonged hyperoxia in neonatal mice. Am J Physiol 1998; 275(1 Pt 1):L110-117
5. Carlton DP, Albertine KH, Cho SC, et al: Role of neutrophils in lung vascular injury and edema after premature birth in lambs. J Appl Physiol 1997; 83:1307-1317
6. Obladen M: Alterations in surfactant composition. In: Bronchopulmonary Dysplasia. Merritt TA, Northway WH, Boynton BR (Eds). Boston, Blackwell Scientific, 1988, pp 131-141
7. Northway WH, Rosan RC, Porter DY: Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med 1967; 276:357-368
8. Hallman M, Merritt TA, Akino T, et al: Surfactant protein A, phosphatidylcholine, and surfactant inhibitors in epithelial lining fluid. Correlations with surface activity, severity of respiratory distress syndrome, and outcome in small premature infants. Am Rev Respir Dis 1991; 144:1376-1384
9. Kazzi SN, Schurch S, McLaughlin KL, et al: Surfactant phospholipids and surface activity among preterm infants with respiratory distress syndrome who develop bronchopulmonary dysplasia. Acta Paediatr 2000; 89:1218-1225
10. Pandit PB, Dunn MS, Colucci EA: Surfactant therapy in neonates with respiratory deterioration due to pulmonary hemorrhage. Pediatrics 1995; 95:32-36
11. Bunt JE, Zimmermann LJ, Wattimena D, et al: Endogenous surfactant turnover in preterm infants measured with stable isotopes. Am J Respir Crit Care Med 1998; 157:810-814
12. Cogo PE, Carnielli VP, Bunt JE, et al: Endogenous surfactant metabolism in critically ill infants measured with stable isotopes labeled fatty acids. Pediatr Res 1999; 45:242-246
13. Torresin M, Zimmermann LJ, Cogo PE, et al: Exogenous surfactant kinetics in infant respiratory distress syndrome: A novel method with stable isotopes. Am J Respir Crit Care Med 2000, 161:1584-1589
14. Ikegami M, Jobe A, Duane G: Liposomes of dipalmitoylphosphatidylcholine associate with natural surfactant. Biochim Biophys Acta 1985; 835:352-359
15. Jacobs H, Jobe A, Ikegami M, et al: The significance of reutilization of surfactant phosphatidylcholine. J Biol Chem 1983; 258:4156-4165
16. Wolfe RR: Radioactive and Stable Isotope Tracers in Biomedicine. New York, Wiley-Liss, 1992
17. Dargaville PA, Douth M, McDougall PN: Comparison of two methods of diagnostic lung lavage in ventilated infants with lung disease. Am J Respir Crit Care Med 1999; 160:771-777
18. Hallman M, Merritt TA, Pohjavouri M, et al: Effect of surfactant substitution on lung effluent phospholipid in respiratory distress syndrome: Evaluation of surfactant phospholipid turnover, pool size, and the relationship to severity of respiratory failure. Pediatr Res 1986; 20:1228-1235
19. Griese M, Dietrich P, Reinhardt D: Pharmacokinetics of bovine surfactant in neonatal respiratory distress syndrome. Am J Respir Crit Care Med 1995; 152:1050-1054
20. Jacobs H, Jobe A, Ikegami M, et al: Surfactant phosphatidylcholine source, fluxes, and turnover times in 3-day-old, 10-day-old, and adult rabbits. J Biol Chem 1982; 257:1805-1810
21. Jobe A, Rider ED: Catabolism and recycling of surfactant. In: Robertson B, Van Golde LM, Batenburg JJ (Eds). Pulmonary Surfactant: From Molecular Biology to Clinical Practice. New York, Elsevier Science Publishers BV, 1992, pp 313-337
22. Jobe AH: Phospholipid metabolism and turnover. In: Polin RA, Fox WW (Eds). Fetal and Neonatal Physiology. Philadelphia, WB Saunders, 1992, pp 896-1013
23. Schmidt R, Meier U, Yabut-Perez M, et al: Alteration of fatty acid profiles in different pulmonary surfactant phospholipids in acute respiratory distress syndrome and severe pneumonia. Am J Respir Crit Care Med 2001; 163:95-100
24. Janssen DJ, Carnielli VP, Cogo PE, et al: Surfactant phosphatidylcholine half-life and pool size measurements in premature baboons developing BPD. Pediatr Res 2002; 52:724-729
25. Seidner SR, Jobe AH, Coalson JJ, et al: Abnormal surfactant metabolism and function in preterm ventilated baboons. Am J Respir Crit Care Med 1998; 158:1982-1989
26. Rebello CM, Jobe AH, Eisele JW, et al: Alveolar and tissue surfactant pool sizes in humans. Am J Respir Crit Care Med 1996; 154:625-628
27. Awasthi S, Coalson JJ, Crouch E, et al: Surfactant proteins A and D in premature baboons with chronic lung injury (bronchopulmonary dysplasia). Evidence for an inhibition of secretion. Am J Respir Crit Care Med 1999; 160:942-949
28. Cavicchioli P, Zimmermann LJ, Cogo PE, et al: Endogenous surfactant turnover in preterm infants with respiratory distress syndrome studied with stable isotope lipids. Am J Respir Crit Care Med 2001; 163:55-60
29. Jobe AH, Kramer BW, Moss TJ, et al: Decreased indicators of lung injury with continuous positive expiratory pressure in preterm lambs. Pediatr Res 2002; 52:387-392
30. Ikegami M, Jobe AH: Injury responses to different surfactants in ventilated premature lamb lungs. Pediatr Res 2002; 51:689-695
31. Coalson JJ, Winter VT, Gerstmann DR, et al: Pathophysiologic, morphometric, and biochemical studies of the premature baboon with bronchopulmonary dysplasia. Am Rev Respir Dis 1992; 145(4 Pt 1): 872-881
32. Ikegami M, Ueda T, Hull W, et al: Surfactant metabolism in transgenic mice after granulocyte macrophage-colony stimulating factor ablation. Am J Physiol 1996; 270(4 Pt 1):L650-658
33. Kotecha S, Wangoo A, Silverman M, et al: Increase in the concentration of transforming growth factor beta-1 in bronchoalveolar lavage fluid before development of chronic lung disease of prematurity. J Pediatr 1996; 128:464-469
34. Jones CA, Cayabyab RG, Kwong KY, et al: Undetectable interleukin (IL)-10 and persistent IL-8 expression early in hyaline membrane disease: A possible developmental basis for the predisposition to chronic lung inflammation in preterm newborns. Pediatr Res 1996; 39:966-975